Background: Bisphenol A (BPA) is widely used and BPA exposure is nearly ubiquitous in developed countries. While animal studies have indicated adverse health effects of prenatal BPA exposure including reproductive dysfunction and thyroid function disruption possibly in a sex-specific manner, findings from epidemiologic studies have not been enough to prove these adverse effects. Given very limited research on human, the aim of this study was to investigate associations between cord blood BPA levels and reproductive and thyroid hormone levels of neonates and whether associations differed by neonate sex. Methods: The study population included 514 participants of the Hokkaido study recruited from 2002 to 2005 at one hospital in Sapporo, Japan. The BPA level in cord blood was determined by ID-LC/ MS/MS, and the limit of quantification was 0.040 ng/ml. We measured nine types of reproductive hormone levels in cord blood, and thyroid hormone levels were obtained from neonate mass screening test data. There were 283 subjects, who had both BPA and hormone levels measurements, included for the final analyses. Results: The geometric mean of cord blood BPA was 0.051 ng/ml. After adjustment, BPA level was negatively associated with prolactin (PRL) (β = −0.38). There was an interaction between infant sex and BPA levels on PRL; a weak negative association was found in boys (β = −0.12), whereas a weak positive association was found in girls (β = 0.14). BPA level showed weak positive association with testosterone, estradiol, and progesterone levels in boys. No association was found between BPA and thyroid hormone levels. Conclusions: Our findings suggested that fetal BPA levels might be associated with changes in certain reproductive hormone levels of neonates in a sex-specific manner, though further investigations are necessary.
B
isphenol A (BPA) is widely used in plastics such as food and drink containers, and as an additive in thermal paper, dental sealant, medical equipment, and flame retardant. BPA exposure is nearly ubiquitous in developed countries as it has been detected in most adults and children [1] [2] [3] as well as amniotic fluid, 4 cord blood, and placental tissue, 5 which indicate in utero BPA exposure. A large number of publications linked BPA exposure to adverse health effects in animal studies. Although evidence from animal studies suggests that exposure to BPA may cause detrimental effects on human health, there are a relatively limited number of studies carried out in humans. Especially, fetal exposure to BPA and its potential influences on their health outcomes are yet largely unknown.
Hormones are some of the most important chemicals and are essential in the process of reproductive health, growth, and development in humans. Among claimed adverse health effects of BPA exposure in epidemiology, studies have found changes in circulating reproductive hormone levels in relation to BPA exposure. [6] [7] [8] [9] BPA has a weak estrogenic property. Experimentally, BPA has shown to interact with estrogen signaling pathways through binding to the estrogen receptors. 10 Further, BPA can act as an antiestrogen 11 and can directly bind to androgen receptors. 12 BPA also act as thyroid hormone agonist and antagonist. 13 There has been only one study focused on associations between cord blood BPA levels and reproductive hormones and their study only focused on boys with and without cryptorchidism. 14 In addition to adverse influences of BPA exposure on reproductive hormones, effects on thyroid hormones are also reported. Thyroid hormones particularly play an essential role in brain development. In vitro studies indicated that BPA might change thyroid homeostasis by modifying thyroid hormone signal pathways. 15 Considering that the structure of BPA is similar to thyroid hormones, the thyroid disrupting activity has been tested in vivo, and some published studies have observed increased serum thyroxine (T4) levels in rat pups with maternal BPA exposure. 13, 16 Several prospective cohort studies have investigated the association between BPA levels and thyroid function and showed suggestive inverse associations with thyroid-stimulating hormone (TSH) and T4 and positive associations with triiodothyronine (T3). 17, 18 From a few prospective birth cohort studies, it has been suggested that prenatal BPA exposure may modify reproductive and/or thyroid hormone homeostasis and may be in a sex-specific manner, yet research on reproductive and thyroid hormone levels in association with prenatal exposure to BPA in humans is very limited. Thus, the aim of this study was to investigate the association between cord blood BPA levels and reproductive and thyroid hormone levels of neonates in a prospective birth cohort study.
MATERIALS AND METHODS

Study Population
This prospective birth cohort study was based on the Sapporo Cohort, Hokkaido Study on Environment and Children's Health. 19 Briefly, we recruited pregnant women at 23-35 weeks of gestation between July 2002 and October 2005 from the Sapporo Toho Hospital in Hokkaido, Japan. All subjects were residents in Sapporo city or surrounding areas. The participants completed the self-administered questionnaire after the second trimester during their pregnancy. The questionnaire contained baseline information including their dietary habits, smoking history, alcohol consumption, caffeine intake, family income, and educational levels of themselves and partners. The perinatal information of the mothers and their children was collected from their medical records. This study was conducted with the informed consent of all participants in written forms. The protocol used in this study was approved by the Institutional ethical board for epidemiologic studies at the Hokkaido University Graduate School of Medicine and Hokkaido University Center for Environment and Health Sciences.
Measurement of Bisphenol A
Cord blood was obtained at delivery. All samples were stored at −80°C until analysis. The concentration of BPA in cord blood was measured by using isotope dilution liquid chromatography-tandem mass spectrometry (ID-LC/MS/MS) at IDEA Consultants, Inc. (Shizuoka, Japan). The details can be found elsewhere. 20 The limit of quantification (LOQ) of BPA was 0.040 ng/ml.
Reproductive Hormone Levels
There were nine types of reproductive hormone levels measured in cord blood at Aska Pharmaceutical Co., Ltd. (Tokyo, Japan). Estradiol (E2), testosterone (T), and progesterone (P4) were measured using LC/MS/MS. Luteinizing hormone (LH), follicle stimulating hormone (FSH), sex hormone-binding globulin (SHBG), and prolactin (PRL) were measured by immunoradiometric assay (IRMA). Inhibin B was measured using Enzyme-Linked Immuno Sorbent Assay (ELISA). Insulin-like factor 3 (INSL3) was measured using Enzyme Immunoassay (EIA). The details of reproductive hormone measurement are found in our previous study.
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Thyroid Hormone Levels
We obtained data of TSH, free T4 (FT4) from a mass screening test for endocrine disorders conducted by Sapporo City Institute of Public Health (Hokkaido, Japan). A heel-prick blood sample of newborns was obtained as spots on a filter paper for the Guthrie test. The blood samples were obtained from infants between 3 and 7 days of age after birth. Blood samples were applied to 0.3-cm filter disks and TSH and FT4 levels were measured using ELISA (TSH: Enzaplate N-TSH; Bayer Co., Tokyo, Japan and FT4: Enzaplate N-FT4; Bayer Co., Tokyo, Japan). The FT4 values of all samples were detected, and for samples with TSH levels below the detection limit (0.50 μU/ml), we used a value of half the detection limit.
Data Analysis
We used the following eligibility criteria for analyses of subjects: no serious illness or complications during pregnancy and delivery; no intake of medication, which may modify maternal hormone levels; singleton babies born at term (37-42 weeks of gestation); and neonates without congenital anomalies or diseases. Among all 514 participants of the Sapporo Cohort Study, 285 cord blood samples for BPA measurements were available. Among those 285 samples, 278 subjects had available reproductive hormone levels and 283 subjects had available thyroid hormone levels.
Since the distributions of cord blood BPA concentrations were right skewed, these variables were transformed by logarithms (log) 10 to improve their linear relation with hormone levels. Reproductive and thyroid hormone levels were also log 10 transformed. BPA concentration below the LOQ was assigned the value of one-half of the LOQ, 0.020 ng/ml. Mann-Whitney test was used for comparisons between boys and girls. To examine the association between cord blood BPA levels and various hormone levels, linear regression models were used. Then models were stratified by infant sex. Estimated marginal means (EMMs) were determined for selected hormone levels in association with tertile BPA levels. Tertiles were to 0.041, 0.042-0.067, and >0.068 ng/ml, respectively. To select covariates to include in the final models, factors known or suspected of being associated with the BPA concentrations and/or hormone levels were reviewed in the literature. The covariates used in this study were child sex and days of mass screening test. All analyses were conducted using SPSS (version 22.0J; SPSS, Chicago, IL).
RESULTS
Basic characteristics of mothers and infants included in this study were shown in Table 1 . The average maternal age at delivery was 30.4 ± 5.0 years (mean ± SD). About half of the participants were nulliparas (51.6%). More than half of the mothers had education longer than 12 years (54.4%), 70.9% had annual income below 5 million yen, and 16.1% of mothers were smoking during pregnancy. The mean birth weight was 3128 ± 33 g, and birth length was 48.5 ± 1.6 cm. The geometric mean of cord blood BPA was 0.051 ng/ml, and the interquartile range (IQR) was <LOQ to 0.076 ng/ml in this study. The detection rate of cord blood BPA was 83.2%.
Distributions of reproductive hormone levels in cord blood and thyroid hormone levels from mass screening data were shown in Table 2 . E2, T, and P4 were detected from 100% of the subjects, and SHBG and PRL were detected from 99.6%. The detection rate of inhibin B was 99.2% in boys; however, only 27.0% in girls. For girls, INSL3 was measured in only 24 participants. Thus, consequently inhibin B and INSL3 were eliminated for the further analyses in girls. LH and FSH were detected from 16.8% to 21.3% of the subjects, respectively. Thus, we did not include these hormones for further analysis. TSH and FT4 were detected from all the subjects. Since reproductive hormone levels were known to have sex differences, sex stratification analysis was conducted. T, P4, and SHBG levels were higher in boys compared with girls.
Adjusted linear regression coefficients (β) of reproductive and thyroid hormone levels in relation to cord blood BPA levels were shown in Table 3 . Cord blood BPA levels were negatively associated with PRL overall (β = −0.38). There was an interaction between infant sex and BPA levels on PRL; a weak negative association was found in boys (β = −0.12), whereas a weak positive association was found in girls (β = 0.14). BPA level showed a weak positive association with T, E2, and P4 levels in boys. Dose-response relationship between tertiles of BPA and selected hormone levels which showed associations with BPA concentrations were shown in Figure. No clear dose-response relationships were found in any of the hormone levels investigated.
DISCUSSION
We observed a weak positive association between cord blood BPA and T, E2, and P4 among boys. However, after stratification of BPA levels into tertiles, dose-response relationships were not found. There was only one published study that investigated the association between perinatal BPA exposure and sex hormone levels only among boys, which found a positive correlation between cord blood BPA and total T and inhibin B in boys without cryptorchidism.
14 However, we did not observe a correlation between cord blood BPA and T and inhibin B among boys. This could be due to much higher cord blood BPA levels in their study (mean ± SD: 1.12 ± 0.86 ng/ ml) compared with ours (mean ± SD: 0.057 ± 0.036 ng/ml). Cross-sectional studies of adults, especially among a male population, have also suggested changes of circulating reproductive hormone levels in relation to BPA exposure. [6] [7] [8] [9] These cross-sectional studies suggested possible interference with aromatase activity by BPA, 6 and direct stimulation by estrogenic activity of BPA. 7 In animal studies, pre-and postnatal exposure to BPA caused a decrease in T of male offspring. 22 On the other hand, prenatal BPA exposure did not change T levels of male offspring. 23 Humans and rodents have vastly different sensitivity levels to estrogen during gestation, and the species difference in free fraction of the steroid in the plasma may magnify the difference in adverse effects of BPA exposure. 24 Thus, the observations from animal studies cannot be easily applied to humans; therefore, epidemiologic studies are necessary to 25 observed an increase in testicular T, whereas decreases in aromatase after 8 weeks of BPA exposure ranged from 0.0005 to 5 mg/kg/bw to adult rats. The main functions of aromatase are to convert T into E2, and longtime exposure to BPA resulted in the inhibition of aromatase activity in an in vitro-based study, 26 which suggested that BPA might increase serum T partially by down-regulating aromatase and further accumulating it via a decrease in the transformation of T into E2. 25 There was no human study that found associations between BPA levels and P4 levels in cord blood. In vitro studies observed a decrease in P4 production following BPA treatments in swine ovarian granulosa cells. 27 Results from animal studies also showed a decrease in P4 in BPA-treated group. 28 Those observations found in experimental studies did not support our observation.
We observed a negative association between BPA and PRL levels. Yet studies of association between BPA and PRL are very limited. PRL plays a critical role in modulating immune and inflammatory responses through various immune signaling pathways. 29 It has been reported in vitro and in vivo studies that BPA mimics E2 and induces hyperprolactinemia. 30 Since the endocrine physiology of pregnancy of animals and humans are quite different, alterations in the secretion of maternal PRL, placental lactogen, and placental androgen, or in the activity of corpus luteum aromatase, it should be well debated that low-dose in utero effects which may be suggested in rats are plausible in human as well. One case-control study suggested that female workers occupationally exposed to BPA showed increased PRL levels. 31 In their study, BPA exposure was an independent risk factor for increased serum PRL levels. 31 Additionally, recent evidence has found that BPA has major stimulatory impacts on PRL release. 29 Further epidemiologic studies, especially prospective studies, are necessary to elucidate associations between BPA and PRL. We found no association between cord blood BPA levels and thyroid hormone levels. Epidemiologic studies have reported a negative association between maternal BPA exposure and neonatal THS levels. 17, 18, 32 Discrepancy between our study and other prospective studies could be explained by the differences in ethnicities, socioeconomic background, and BPA exposure levels. The cord blood BPA levels in this study were much lower compared with the previous reports. 3, 17 Sample size might be also one of the reasons to see the discrepancy between studies. Additionally, coexposures assessment and method of thyroid hormone measurements, whether heelprick blood or cord blood, or timing of thyroid hormone measurement could be a reason of discrepant results.
It is known that thyroid hormone is essential for fetal and child growth and brain development, thus interference with thyroid hormone circulation by BPA exposure may have effects on development. Although results were not consistent among studies, animal studies have shown associations between prenatal BPA exposure and thyroid hormone levels of pups. 13, 15 Inconsistencies from these studies could be due to different doses of BPA, different timing and duration of BPA exposure, and different animals. Besides, it is difficult to lead conclusions from these rodent studies as metabolic pathways of BPA were different between rodents and humans. 33 For instance, orally dosed BPA in rodents are excreted through the bile with reabsorption by guts, whereas in humans, orally taken BPA is metabolized in the liver and then enters the bloodstream. Additionally, humans are likely to be exposed to lower levels of BPA but chronically; in animal models, they are often exposed to higher levels compared with humans.
In our study, BPA in cord blood was measured as prenatal exposure, whereas maternal urine samples were used in the other epidemiologic studies. BPA levels in cord blood were more directly representative of fetal exposure rather than maternal exposure; on the other hand, our study was not able to assess early fetal exposure. BPA can be measured in serum as well as urine. 34 Although urinary BPA testing is less invasive, it measures BPA excreted, which is not exactly reflecting the current in vivo exposure. Thus, serum BPA may be better for exposure assessment. 35 Besides, in studies used urinary BPA as exposure measurements, intra-individual variability of BPA concentrations was moderately correlated 36 and accurately characterizing exposure from a single measurement was difficult. Meanwhile using mean concentration of urinary BPA from several measurements would decrease the ability to identify a time-sensitive window of development. 37 We should note that measurement of BPA in blood samples has left space for further discussion as BPA blood concentration was possibly overestimated due to external contamination. In our method of BPA measurements, we used glass cartridges instead of polypropylene to reduce background levels and no free BPA was detected from samples, which was an indication of null possible external contamination.
The limitations of this study need to be considered. First, there was limited statistical power with our sample size. Additionally, there have been concerns whether single measurement of cord blood sample represented the long-term prenatal BPA exposure due to short half-lives of BPA and there might be a possibility of accidental exposure near blood drawing period. However, in this study, only vaginal births were included and chances were small that medical equipment such as syringes or tubes, which possibly contained BPA, were used during the process of delivery. Thus, we believe that accidental exposure did not occur. There might be a chance of selection bias in this study as we only included participants with available cord blood samples and reproductive and thyroid hormone levels. However, the comparison between the original cohort profile and the present study profile did not show discrepancies. The strength of our study was that we used the BPA levels of cord blood, which accurately indicated the fetus' exposure. However, more studies are necessary to confirm the adverse effect of prenatal BPA exposure as developmental exposure can result in changes in gene expression that may not produce observable effects at birth but may increase the risk of adverse health outcomes later in life.
CONCLUSION
Our findings suggest a negative association between cord blood BPA levels and PRL levels overall. The association was sex specific: a negative association was found in boys, whereas a positive association was found in girls. We also found suggestive positive associations between BPA levels and T, E2, and P4 in boys. In an ongoing cohort, effects on reproductive hormone levels need to be investigated at the pubertal stage in association with prenatal BPA exposure.
